molecular modeling of nanoscale bioassemblies for clinical laboratory diagnostics

21
Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics City of Hope National Medical Center Scott F. Roalofs with Dr. Steven S. Smith

Upload: courtney

Post on 27-Jan-2016

44 views

Category:

Documents


0 download

DESCRIPTION

Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics. City of Hope National Medical Center Scott F. Roalofs with Dr. Steven S. Smith. Overview. Purpose Introduction to Bionanotechnology FRET Modification of Bioassemblies Molecular Models Conclusions - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

City of Hope National Medical Center

Scott F. Roalofswith

Dr. Steven S. Smith

Page 2: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Overview

Purpose Introduction to Bionanotechnology FRET Modification of Bioassemblies Molecular Models Conclusions Acknowledgements

Page 3: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Purpose

To design and develop a tool that would allow rapid diagnose of tumor cells from a biopsy My specific part: Modeling of

bioassemblies using Insight II

Page 4: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Y-Junction

Ni Linker StructureFluorescent Molecules

Tumor Cell

Page 5: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Bionanotechnology

Uses molecular biology, chemistry and physics to link molecules into complex assemblies

Must be under 100nm in its largest dimension

Artificial and require some assembly outside of a living system

Page 6: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

FRET

Förster resonance energy transfer Fluorescent donor is excited at its

specific excitation wavelength Dipole-dipole interactions:

Excited state is non-radioactively transferred to an acceptor

Acceptor returns to the electronic ground state

Page 7: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Changing Target Specificity DNA methyltransferase HhaI has

the ability to be targeted to specific recognition sites in the Y-Junction

Covalently trapped on duplex DNA using 5’-fluorocytosine

Bioassemblies can be modified with various targeting and detection chemistries

Page 8: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Y-Junction Structure

Page 9: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Fluorine

Fluorine

FluorineFluorine

Fluorine

Page 10: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Sulfur Linker Structure

3’

5’

oligomer

oligomerN

S

S O

O

O

P

HO

O

O

OHC

C

O-

O-

O

O

S

O

P O

O

O-

O P

HO

O

O-

HO

S

O

O

N

C

C

O-

O-

O

O

IDA

Page 11: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Sulfur Linker

17,234 kcal/mol

Page 12: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Previous work Horsey et al., Chem Comm, 2002,

1950-51. Compared chelated vs. non-

chelated Sulfur Linker complex 15°C difference in Tm: chelated vs.

non-chelated Sulfur Linker complex Smith lab has been unable to

reproduce these results

Page 13: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

6 Linker Structure

N

(CH2)6

S O P

HO

O

O

OHC

C

O-

O-

O

O

3’

ologomer

5’

oligomer

(CH2)6

S

O

P O

O

O-

O P

HO

O

O-

HO

N

C

C

O-

O-

O

O

IDA

Page 14: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

6 Linker

17,249 kcal/mol

Page 15: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Linker Modifications

Linker structures were modified Previous models identified possible

unwanted interactions with Ni Synthesis protocol was modified

Removed (CH2)3 OH Replaced with a Cytosine base

Page 16: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Modified Linker

Page 17: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Conclusions

Models are visually appealing for use in presenting one’s ideas

Molecular modeling provides 3D visual renderings of hand drawn structures Models may identify questionable

structure flaws that may not have be noticeable on a hand drawn structure

Page 18: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Acknowledgements

Dr. Steven S. Smith Jarrod Clark Katarzyna Lamparska-Kupsik SoCalBSI NIH

Page 19: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

Questions ?

Page 20: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

FRET

www.olympusfluoview.com/applications/fretinfo.html

Page 21: Molecular Modeling of Nanoscale Bioassemblies for Clinical Laboratory Diagnostics

IDA=iminodiacetic acid